IRVINE, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today they have submitted to the FDA an EUA application for an ELISA lab-based serology blood test for the ...
Avacta Group plc, the developer of Affimer ® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global ...
Enzyme-linked immunosorbent Assay (ELISA) is a core immunology technique that enables the detection and quantification of various substances, including peptides, antibodies, proteins, and hormones.
CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory ...
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Lab Automation Market by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, Automated ELISA, Software), End ...
A desire for a simpler, cheaper way to do common laboratory tests for medical diagnoses and to avoid 'washing the dishes' led researchers to develop a new technology that reduces cost and time. The 3D ...
IRVINE, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today they have submitted to the FDA an EUA application for an ELISA lab-based serology blood test for the ...
Avacta Group, a developer of Affimer biotherapeutics and reagents, announced that it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results